ストックスクリーナーアプリを入手
0.8879
4.01%
0.0342
アフターアワーズ：
.86
-0.0279
-3.14%
前日終値:
$0.8537
開ける：
$0.858
24時間の取引高:
924.76K
Relative Volume:
0.27
時価総額：
$3.71M
収益：
$10.48M
当期純損益:
$-37.74M
株価収益率:
-0.0549
EPS:
-16.1846
ネットキャッシュフロー:
$-29.03M
1週間 パフォーマンス:
+45.80%
1か月 パフォーマンス:
+25.93%
6か月 パフォーマンス:
-49.84%
1年 パフォーマンス:
-93.83%
1日の値動き範囲:
$0.81
$0.9221
1週間の範囲:
$0.59
$0.9221
52週間の値動き範囲:
$0.56
$15.75
Jaguar Health Inc Stock (JAGX) Company Profile
名前
Jaguar Health Inc
セクター
電話
415-371-8300
住所
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Compare JAGX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
0.8879 | 3.56M | 10.48M | -37.74M | -29.03M | -16.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
496.83 | 121.97B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
781.67 | 81.49B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
766.92 | 47.74B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
332.92 | 43.93B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
316.99 | 35.67B | 4.98B | 69.60M | 525.67M | 0.5198 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-07-11 | 開始されました | Rodman & Renshaw | Buy |
Jaguar Health Inc (JAGX) 最新ニュース
Is Jaguar Health Inc stock showing strong momentumJuly 2025 Action & Real-Time Sentiment Analysis - baoquankhu1.vn
Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates - The Coloradoan
JAGX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference - 富途牛牛
Jaguar Health (JAGX) Announces Special Stock Dividend with Conve - GuruFocus
Jaguar Declares Special Stock Dividend to Protect Shareholders - Intellectia AI
Jaguar Health Declares Special Convertible Preferred Stock Dividend - TipRanks
Jaguar Health to Pay Special Stock Dividend - marketscreener.com
Jaguar Health Announces a Special One-time Stock Dividend - ACCESS Newswire
Hedge Fund Moves: Should value investors consider Jaguar Health IncJuly 2025 Volume & AI Driven Stock Price Forecasts - baoquankhu1.vn
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Treasure Coast News
Jaguar Animal Health to Host Treatment Forum for Veterinarians About Chemotherapy-Induced Diarrhea (CID) in Dogs on Sunday, March 6th, During the Western Veterinary Conference (WVC) in Las Vegas - ACCESS Newswire
Is Jaguar Health Inc. stock a safe buy before earningsQuarterly Investment Review & AI Based Trade Execution Alerts - mfd.ru
Will Jaguar Health Inc. benefit from current market trendsGap Up & Low Risk Investment Opportunities - mfd.ru
Bull Bear: Is Howard Hughes Holdings Inc a cyclical or defensive stockJuly 2025 Final Week & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Is Jaguar Health Inc. undervalued by DCF analysisWeekly Trade Summary & High Win Rate Trade Tips - mfd.ru
Is Jaguar Health Inc. stock showing strong momentum2025 Big Picture & Weekly High Return Stock Opportunities - mfd.ru
Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): BUY - TradingView
Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million - Marco Eagle
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Jaguar Health Presenting January 15 at Lytham Partners Healthcare Investor Summit to Provide Updates on Near-Term Catalysts - The Marion Star
Should value investors consider Jaguar Health Inc.July 2025 Opening Moves & Weekly Breakout Watchlists - mfd.ru
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue - hattiesburgamerican.com
Jaguar Health Executes Debt-Reducing Equity Warrant Transactions - TipRanks
Jaguar Health Signs Multiple Material Agreements - TradingView
Jaguar Health (JAGX) Advances Rare Disease Program with Focus on Crofelemer - GuruFocus
Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi - Lansing State Journal
Jaguar trial cuts children’s IV support needs by up to 37% - Stock Titan
Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs - barnstablepatriot.com
Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs - Pueblo Chieftain
Earnings Report: Is Jaguar Health Inc a defensive stock2025 Valuation Update & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Jaguar Health Inc (JAGX) 財務データ
収益
当期純利益
現金流量
EPS
1.18%
0.45%
大文字化:
|
ボリューム (24 時間):